Efficacy of oral antiviral drugs to prevent mother-to-child transmission of hepatitis B virus: a network meta-analysis
- 4 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Hepatology International
- Vol. 14 (3), 338-346
- https://doi.org/10.1007/s12072-020-10024-2
Abstract
Background Hepatitis B is a serious global health problem. Mother-to-child transmission (MTCT) of hepatitis B virus (HBV) is a major risk factor in the endemicity of HBV infection. Oral antiviral drugs are recommended to highly viremic mothers to decrease MTCT of HBV. The present network analysis compared the efficacy of available treatments to prevent the MTCT of HBV. Methods The electronic databases of PubMed, Embase, Web of Science, Scopus, and Wanfang data were searched for eligible studies. Pair-wise meta-analysis and Bayesian network analysis were applied to compare the efficacy of antiviral drugs. Results Seventy-five studies involving 12,740 pregnant females were eligible for analysis. On pair-wise analysis, lamivudine (OR 0.15, 95% CI 0.09–0.25, I-squared = 0%), telbivudine (OR 0.07, 95% CI 0.05–0.10, I-squared = 0%) and tenofovir (OR 0.07, 95% CI 0.04–0.13, I-squared = 0%) significantly decreased the MTCT rate. Results of multiple comparisons with ranking probability based on Bayesian analysis showed that tenofovir (SUCRA = 96.83%) appeared more effective than the two other drugs. Conclusion In addition to active and passive immunoprophylaxis, lamivudine, telbivudine and tenofovir in highly viremic mothers can further decrease MTCT of HBV. Based on direct and indirect evidence, tenofovir appears to be more effective than the two other drugs in the prevention of HBV MTCT.Keywords
Funding Information
- National Natural Science Foundation of China (81770570, 81801990)
- Chongqing Basic and Frontier Research Project (cstc2019jcyj-msxmX0007)
This publication has 28 references indexed in Scilit:
- Medical Virology of Hepatitis B: how it began and where we are nowVirology Journal, 2013
- Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancyJournal of Viral Hepatitis, 2012
- Efficacy of peripartum antiviral treatment for hepatic failure due to hepatitis B virusInternational Journal of Gynecology & Obstetrics, 2011
- Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorialJournal of Clinical Epidemiology, 2011
- Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis BGastroenterology, 2011
- Clearance of Hepatitis B e Antigen in Patients With Chronic Hepatitis B and Genotypes A, B, C, D, and FGastroenterology, 2007
- Two Decades of Universal Hepatitis B Vaccination in Taiwan: Impact and Implication for Future StrategiesGastroenterology, 2007
- Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothersEmergencias, 2006
- Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in ChildrenThe New England Journal of Medicine, 1997
- Outcome Of Perinatal Hepatitis B Virus Exposure Is Dependent On Maternal Virus LoadThe Journal of Infectious Diseases, 1994